Three Wall Street names — Fortress Investment Group, Ares Management and Platinum Equity — are among the firms poised to absorb complete write-offs after a leveraged buyout of a portable-toilet business collapsed, according to a report by Bloomberg.
Ares Management has entered into a strategic partnership with Mubadala Investment Company and the Abu Dhabi Investment Council to create a new investment vehicle focused on acquiring minority stakes in mid-size private equity firms, according to a report by Bloomberg.
Global private equity firm TPG has teamed up with Tata Consultancy Services (TCS) to launch a $2bn joint venture dedicated to building AI-focused data centres across India, as institutional capital continues to pour into digital infrastructure, according to a report by Reuters.
Blue Owl Capital is considering revisiting a proposed merger between its publicly traded Blue Owl Capital Corporation (OBDC), and its privately held sibling, Blue Owl Capital Corporation II, contingent on an improvement in OBDC’s share price so that the fund is not trading at a discount to its net asset
Blackstone Inc and Neuberger Berman Group LLC have committed at least $600m to a continuation vehicle launched by Trilantic Capital Partners, according to a report by Bloomberg citing people familiar with the matter.
The South Korean government has successfully overturned a $216.5m damages ruling in its long-running dispute with US private equity firm Lone Star Funds over the 2003 sale of Korea Exchange Bank (KEB), according to a report by Reuters.
KKR & Co has opened an office in Abu Dhabi’s financial centre, strengthening its presence in the Middle East. The office will be led by Julian Barratt-Due, a managing director overseeing KKR’s regional investment business, according to a report by Bloomberg.
CVC Capital Partners, one of the world’s largest private equity managers, has reported realisations of €15.4bn as of end-September, ahead of its previous full-year guidance.
Medicxi, a European life sciences venture capital firm, has closed Medicxi V, a €500m fund dedicated to building and backing biotechnology companies. The oversubscribed fund closed with support from existing limited partners and a select group of new institutional investors. The fund will focus on Medicxi’s asset-centric investment model.
Software-focused sponsor Vista Equity Partners has informed its investors of plans to significantly reduce its workforce as the firm accelerates the integration of artificial-intelligence platforms, according to a report by the Financial Times.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
